Self-infusing with Hizentra prefilled syringes
Before switching to Hizentra, obtain the patient’s serum IgG trough level to guide subsequent dose adjustments.
Weekly
Biweekly (every 2 weeks)
Frequent dosing (2 to 7 times per week)
Start Hizentra 1 week after last Intravenous Immune Globulin (Human) (IVIg) infusion.
Initial weekly dose = (Previous IVIg dose [in grams]/No. of weeks between IVIg doses) X 1.37
Start Hizentra 1 or 2 weeks after last IVIg infusion or 1 week after the last weekly SCIg infusion.
Administer twice the calculated weekly dose.
Start Hizentra 1 week after last IVIg or SCIg infusion.
Divide the calculated weekly dose by the desired number of times per week.
Adjust the dose based on clinical response and serum IgG trough levels.
Hizentra should be administered subcutaneously (SC) only. Do not administer intravenously. Hizentra can be dosed daily up to every 2 weeks for PI using an infusion pump and relatively small needle(s).
Explore tools and information to help you tailor treatment to individual patient needs
Dosing calculatorSign up for free online administration training—and become a SHARE Hizentra administration specialist
Start SHARE trainingInformation and resources are available to help patients manage their ongoing administration of Hizentra
Managing therapy